Steven L. Roberds
YOU?
Author Swipe
View article: Cutaneous manifestations-associated with tuberous sclerosis complex and the use of topical rapamycin in the United States: a sub-analysis of an international survey of caregivers and patients
Cutaneous manifestations-associated with tuberous sclerosis complex and the use of topical rapamycin in the United States: a sub-analysis of an international survey of caregivers and patients Open
View article: The role of the TSC Alliance in advancing therapy development: a patient organization perspective
The role of the TSC Alliance in advancing therapy development: a patient organization perspective Open
Tuberous sclerosis complex (TSC) is a genetic disease leading to malformations, or tubers, in the cerebral cortex and growth of tumors, most frequently in the brain, heart, kidneys, skin, and lungs. Changes in the brain caused by TSC usual…
View article: Characterization and management of facial angiofibroma related to tuberous sclerosis complex in the United States: retrospective analysis of the natural history database
Characterization and management of facial angiofibroma related to tuberous sclerosis complex in the United States: retrospective analysis of the natural history database Open
View article: Characterization and Management of Facial Angiofibroma Related to Tuberous Sclerosis Complex in the United States: Retrospective Analysis of the Natural History Database
Characterization and Management of Facial Angiofibroma Related to Tuberous Sclerosis Complex in the United States: Retrospective Analysis of the Natural History Database Open
Background: Facial angiofibroma is the most predominant cutaneous manifestation of tuberous sclerosis complex (TSC), a rare autosomal dominant genetic disorder impacting the mechanistic target of rapamycin (mTOR). Facial angiofibroma can b…
View article: Inhibition of MEK-ERK signaling reduces seizures in two mouse models of tuberous sclerosis complex
Inhibition of MEK-ERK signaling reduces seizures in two mouse models of tuberous sclerosis complex Open
View article: Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations
Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations Open
View article: Epilepsy Community at an Inflection Point: Translating Research Toward Curing the Epilepsies and Improving Patient Outcomes
Epilepsy Community at an Inflection Point: Translating Research Toward Curing the Epilepsies and Improving Patient Outcomes Open
View article: Approach to Preventive Epilepsy Treatment in Tuberous Sclerosis Complex and Current Clinical Practice in 23 Countries
Approach to Preventive Epilepsy Treatment in Tuberous Sclerosis Complex and Current Clinical Practice in 23 Countries Open
Despite the lack of published results of randomized trials, the concepts of preseizure EEG monitoring and epilepsy prevention are already being implemented in the majority of surveyed centers.
View article: Epilepsy Risk Prediction Model for Patients With Tuberous Sclerosis Complex
Epilepsy Risk Prediction Model for Patients With Tuberous Sclerosis Complex Open
View article: Pilot Study of Neurodevelopmental Impact of Early Epilepsy Surgery in Tuberous Sclerosis Complex
Pilot Study of Neurodevelopmental Impact of Early Epilepsy Surgery in Tuberous Sclerosis Complex Open
View article: Factors Associated with Caregiver Sleep Quality Related to Children with Rare Epilepsy Syndromes
Factors Associated with Caregiver Sleep Quality Related to Children with Rare Epilepsy Syndromes Open
View article: Tuberous Sclerosis Complex Genotypes and Developmental Phenotype
Tuberous Sclerosis Complex Genotypes and Developmental Phenotype Open
View article: High vigabatrin dosage is associated with lower risk of infantile spasms relapse among children with tuberous sclerosis complex
High vigabatrin dosage is associated with lower risk of infantile spasms relapse among children with tuberous sclerosis complex Open
After initially successful treatment of infantile spasms, the long-term cumulative risk of relapse approaches 50%, and there is no established protocol to mitigate this risk. Although vigabatrin may be an effective means to prevent relapse…
View article: Advances and Future Directions for Tuberous Sclerosis Complex Research: Recommendations From the 2015 Strategic Planning Conference
Advances and Future Directions for Tuberous Sclerosis Complex Research: Recommendations From the 2015 Strategic Planning Conference Open